Replimune Group Market Cap

Replimune Group has a market cap or net worth of $598.65 million as of March 5, 2026. Its market cap has decreased by -44.87% in one year.

Market Cap

598.65M

Enterprise Value

405.86M

1-Year Change

-44.87%

Ranking

#2928

Market Cap Chart

Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $598.65M, an increase of 28.05%. That is a compound annual growth rate of 3.30%.

Market Cap History

Date	Market Cap	% Change
Mar 3, 2026	592.05M	-22.35%
Dec 31, 2025	762.47M	-18.18%
Dec 31, 2024	931.93M	87.18%
Dec 29, 2023	497.87M	-67.63%
Dec 30, 2022	1.54B	21.04%
Dec 31, 2021	1.27B	-27.53%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ocugen	636.10M
Rigel Pharmaceuticals	628.40M
MeiraGTx Holdings	610.12M
YD Bio	608.27M
LB Pharmaceuticals	601.61M
Allogene Therapeutics	595.53M
Design Therapeutics	582.74M
CorMedix	568.07M

Market Cap Rankings